First Invisicare Delivery Technology Product from Skinvisible (OTCMKTS:SKVI) Gets U.S. FDA Acceptance of Investigational New Drug
Skinvisible Inc. (OTCMKTS:SKVI) announced on June 6, 2022, that its licensee Quoin Pharmaceuticals, Inc. has got the U.S. FDA acceptance
Read more